nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—mammary gland—sarcoma	0.0257	0.168	CbGeAlD
Lorazepam—TSPO—hindlimb—sarcoma	0.022	0.144	CbGeAlD
Lorazepam—TSPO—appendage—sarcoma	0.0189	0.124	CbGeAlD
Lorazepam—UGT2B15—liver—sarcoma	0.0081	0.0532	CbGeAlD
Lorazepam—TSPO—myometrium—sarcoma	0.00652	0.0428	CbGeAlD
Lorazepam—TSPO—embryo—sarcoma	0.00627	0.0412	CbGeAlD
Lorazepam—TSPO—seminal vesicle—sarcoma	0.00589	0.0387	CbGeAlD
Lorazepam—TSPO—hematopoietic system—sarcoma	0.0056	0.0367	CbGeAlD
Lorazepam—TSPO—connective tissue—sarcoma	0.00539	0.0354	CbGeAlD
Lorazepam—TSPO—smooth muscle tissue—sarcoma	0.00493	0.0324	CbGeAlD
Lorazepam—GABRB3—connective tissue—sarcoma	0.00489	0.0321	CbGeAlD
Lorazepam—TSPO—skin of body—sarcoma	0.00487	0.0319	CbGeAlD
Lorazepam—TSPO—cardiac atrium—sarcoma	0.00425	0.0279	CbGeAlD
Lorazepam—TSPO—uterus—sarcoma	0.00423	0.0278	CbGeAlD
Lorazepam—TSPO—lymphoid tissue—sarcoma	0.00394	0.0259	CbGeAlD
Lorazepam—Pancytopenia—Vincristine—sarcoma	0.00389	0.00459	CcSEcCtD
Lorazepam—Agranulocytosis—Thiotepa—sarcoma	0.00385	0.00454	CcSEcCtD
Lorazepam—Agranulocytosis—Dactinomycin—sarcoma	0.00382	0.0045	CcSEcCtD
Lorazepam—Pancytopenia—Mitoxantrone—sarcoma	0.00379	0.00447	CcSEcCtD
Lorazepam—Erectile dysfunction—Vincristine—sarcoma	0.00377	0.00445	CcSEcCtD
Lorazepam—Ventricular arrhythmia—Doxorubicin—sarcoma	0.00371	0.00437	CcSEcCtD
Lorazepam—TSPO—tendon—sarcoma	0.00371	0.0243	CbGeAlD
Lorazepam—Hallucination—Thiotepa—sarcoma	0.00368	0.00434	CcSEcCtD
Lorazepam—Erectile dysfunction—Mitoxantrone—sarcoma	0.00368	0.00434	CcSEcCtD
Lorazepam—Cardiac arrest—Etoposide—sarcoma	0.00365	0.00431	CcSEcCtD
Lorazepam—Injection site pain—Epirubicin—sarcoma	0.00363	0.00429	CcSEcCtD
Lorazepam—TSPO—bone marrow—sarcoma	0.00359	0.0236	CbGeAlD
Lorazepam—Drowsiness—Mitoxantrone—sarcoma	0.00356	0.0042	CcSEcCtD
Lorazepam—Liver injury—Epirubicin—sarcoma	0.00353	0.00416	CcSEcCtD
Lorazepam—Jaundice—Mitoxantrone—sarcoma	0.00347	0.00409	CcSEcCtD
Lorazepam—Delirium—Epirubicin—sarcoma	0.00345	0.00407	CcSEcCtD
Lorazepam—Injection site pain—Doxorubicin—sarcoma	0.00336	0.00397	CcSEcCtD
Lorazepam—Agranulocytosis—Mitoxantrone—sarcoma	0.00332	0.00392	CcSEcCtD
Lorazepam—Chills—Thiotepa—sarcoma	0.00332	0.00392	CcSEcCtD
Lorazepam—Arrhythmia—Thiotepa—sarcoma	0.0033	0.0039	CcSEcCtD
Lorazepam—Chills—Dactinomycin—sarcoma	0.00329	0.00389	CcSEcCtD
Lorazepam—Alopecia—Thiotepa—sarcoma	0.00327	0.00386	CcSEcCtD
Lorazepam—Hallucination—Vincristine—sarcoma	0.00326	0.00385	CcSEcCtD
Lorazepam—Liver injury—Doxorubicin—sarcoma	0.00326	0.00385	CcSEcCtD
Lorazepam—Bradycardia—Mitoxantrone—sarcoma	0.00325	0.00384	CcSEcCtD
Lorazepam—Alopecia—Dactinomycin—sarcoma	0.00324	0.00383	CcSEcCtD
Lorazepam—Thinking abnormal—Epirubicin—sarcoma	0.00324	0.00382	CcSEcCtD
Lorazepam—Erythema—Thiotepa—sarcoma	0.00322	0.0038	CcSEcCtD
Lorazepam—Erythema—Dactinomycin—sarcoma	0.0032	0.00377	CcSEcCtD
Lorazepam—Delirium—Doxorubicin—sarcoma	0.00319	0.00376	CcSEcCtD
Lorazepam—Tension—Thiotepa—sarcoma	0.00316	0.00373	CcSEcCtD
Lorazepam—Pancytopenia—Etoposide—sarcoma	0.00315	0.00372	CcSEcCtD
Lorazepam—Dysarthria—Epirubicin—sarcoma	0.00314	0.0037	CcSEcCtD
Lorazepam—Nervousness—Thiotepa—sarcoma	0.00313	0.00369	CcSEcCtD
Lorazepam—TSPO—testis—sarcoma	0.00307	0.0201	CbGeAlD
Lorazepam—Atrioventricular block—Epirubicin—sarcoma	0.00306	0.00361	CcSEcCtD
Lorazepam—Vision blurred—Thiotepa—sarcoma	0.00304	0.00358	CcSEcCtD
Lorazepam—Thinking abnormal—Doxorubicin—sarcoma	0.003	0.00354	CcSEcCtD
Lorazepam—Hepatocellular injury—Epirubicin—sarcoma	0.00297	0.0035	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Epirubicin—sarcoma	0.00297	0.0035	CcSEcCtD
Lorazepam—Agitation—Thiotepa—sarcoma	0.00296	0.00349	CcSEcCtD
Lorazepam—Injection site reaction—Epirubicin—sarcoma	0.00295	0.00348	CcSEcCtD
Lorazepam—Dysarthria—Doxorubicin—sarcoma	0.0029	0.00342	CcSEcCtD
Lorazepam—TSPO—liver—sarcoma	0.0029	0.019	CbGeAlD
Lorazepam—Alopecia—Vincristine—sarcoma	0.0029	0.00342	CcSEcCtD
Lorazepam—Cystitis noninfective—Epirubicin—sarcoma	0.0029	0.00342	CcSEcCtD
Lorazepam—Jaundice—Etoposide—sarcoma	0.00289	0.0034	CcSEcCtD
Lorazepam—Salivary hypersecretion—Epirubicin—sarcoma	0.00288	0.0034	CcSEcCtD
Lorazepam—Chills—Mitoxantrone—sarcoma	0.00287	0.00338	CcSEcCtD
Lorazepam—Cystitis—Epirubicin—sarcoma	0.00286	0.00338	CcSEcCtD
Lorazepam—Arrhythmia—Mitoxantrone—sarcoma	0.00285	0.00337	CcSEcCtD
Lorazepam—Atrioventricular block—Doxorubicin—sarcoma	0.00283	0.00334	CcSEcCtD
Lorazepam—Alopecia—Mitoxantrone—sarcoma	0.00282	0.00333	CcSEcCtD
Lorazepam—Convulsion—Thiotepa—sarcoma	0.00279	0.00329	CcSEcCtD
Lorazepam—GABRB3—testis—sarcoma	0.00279	0.0183	CbGeAlD
Lorazepam—Erythema—Mitoxantrone—sarcoma	0.00278	0.00328	CcSEcCtD
Lorazepam—Hypertension—Thiotepa—sarcoma	0.00278	0.00328	CcSEcCtD
Lorazepam—Agranulocytosis—Etoposide—sarcoma	0.00276	0.00326	CcSEcCtD
Lorazepam—Hepatocellular injury—Doxorubicin—sarcoma	0.00274	0.00324	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.00274	0.00324	CcSEcCtD
Lorazepam—Injection site reaction—Doxorubicin—sarcoma	0.00273	0.00322	CcSEcCtD
Lorazepam—Coma—Epirubicin—sarcoma	0.00271	0.0032	CcSEcCtD
Lorazepam—Bladder pain—Epirubicin—sarcoma	0.00268	0.00316	CcSEcCtD
Lorazepam—Cystitis noninfective—Doxorubicin—sarcoma	0.00268	0.00316	CcSEcCtD
Lorazepam—Salivary hypersecretion—Doxorubicin—sarcoma	0.00267	0.00314	CcSEcCtD
Lorazepam—Cystitis—Doxorubicin—sarcoma	0.00265	0.00313	CcSEcCtD
Lorazepam—Confusional state—Thiotepa—sarcoma	0.00265	0.00313	CcSEcCtD
Lorazepam—Pulmonary oedema—Epirubicin—sarcoma	0.00264	0.00311	CcSEcCtD
Lorazepam—GABRB3—liver—sarcoma	0.00263	0.0173	CbGeAlD
Lorazepam—Agitation—Vincristine—sarcoma	0.00262	0.0031	CcSEcCtD
Lorazepam—Vision blurred—Mitoxantrone—sarcoma	0.00262	0.00309	CcSEcCtD
Lorazepam—Infection—Thiotepa—sarcoma	0.00261	0.00308	CcSEcCtD
Lorazepam—Infection—Dactinomycin—sarcoma	0.00259	0.00306	CcSEcCtD
Lorazepam—Mental disability—Epirubicin—sarcoma	0.00257	0.00304	CcSEcCtD
Lorazepam—Thrombocytopenia—Thiotepa—sarcoma	0.00257	0.00304	CcSEcCtD
Lorazepam—Vertigo—Vincristine—sarcoma	0.00257	0.00303	CcSEcCtD
Lorazepam—Tachycardia—Thiotepa—sarcoma	0.00257	0.00303	CcSEcCtD
Lorazepam—Thrombocytopenia—Dactinomycin—sarcoma	0.00255	0.00301	CcSEcCtD
Lorazepam—Coma—Doxorubicin—sarcoma	0.00251	0.00296	CcSEcCtD
Lorazepam—Bladder pain—Doxorubicin—sarcoma	0.00248	0.00293	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.00248	0.00292	CcSEcCtD
Lorazepam—Convulsion—Vincristine—sarcoma	0.00247	0.00292	CcSEcCtD
Lorazepam—Hypertension—Vincristine—sarcoma	0.00247	0.00291	CcSEcCtD
Lorazepam—Pulmonary oedema—Doxorubicin—sarcoma	0.00244	0.00288	CcSEcCtD
Lorazepam—Convulsion—Mitoxantrone—sarcoma	0.00241	0.00284	CcSEcCtD
Lorazepam—Hypertension—Mitoxantrone—sarcoma	0.0024	0.00283	CcSEcCtD
Lorazepam—Chills—Etoposide—sarcoma	0.00238	0.00281	CcSEcCtD
Lorazepam—Mental disability—Doxorubicin—sarcoma	0.00238	0.00281	CcSEcCtD
Lorazepam—Alopecia—Etoposide—sarcoma	0.00235	0.00277	CcSEcCtD
Lorazepam—Somnolence—Thiotepa—sarcoma	0.00234	0.00276	CcSEcCtD
Lorazepam—Infection—Vincristine—sarcoma	0.00232	0.00273	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.00229	0.0027	CcSEcCtD
Lorazepam—Confusional state—Mitoxantrone—sarcoma	0.00229	0.0027	CcSEcCtD
Lorazepam—Thrombocytopenia—Vincristine—sarcoma	0.00228	0.00269	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Thiotepa—sarcoma	0.00227	0.00268	CcSEcCtD
Lorazepam—Fatigue—Thiotepa—sarcoma	0.00227	0.00267	CcSEcCtD
Lorazepam—Infection—Mitoxantrone—sarcoma	0.00225	0.00266	CcSEcCtD
Lorazepam—Fatigue—Dactinomycin—sarcoma	0.00225	0.00265	CcSEcCtD
Lorazepam—Constipation—Thiotepa—sarcoma	0.00225	0.00265	CcSEcCtD
Lorazepam—Pain—Thiotepa—sarcoma	0.00225	0.00265	CcSEcCtD
Lorazepam—Pain—Dactinomycin—sarcoma	0.00223	0.00263	CcSEcCtD
Lorazepam—TSPO—lymph node—sarcoma	0.00222	0.0146	CbGeAlD
Lorazepam—Thrombocytopenia—Mitoxantrone—sarcoma	0.00222	0.00262	CcSEcCtD
Lorazepam—Tachycardia—Mitoxantrone—sarcoma	0.00222	0.00261	CcSEcCtD
Lorazepam—Lethargy—Epirubicin—sarcoma	0.0022	0.00259	CcSEcCtD
Lorazepam—Hypotension—Vincristine—sarcoma	0.00218	0.00257	CcSEcCtD
Lorazepam—Feeling abnormal—Thiotepa—sarcoma	0.00217	0.00256	CcSEcCtD
Lorazepam—Hyponatraemia—Epirubicin—sarcoma	0.00216	0.00255	CcSEcCtD
Lorazepam—Osteoarthritis—Epirubicin—sarcoma	0.00215	0.00254	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.00215	0.00254	CcSEcCtD
Lorazepam—Diplopia—Epirubicin—sarcoma	0.00215	0.00254	CcSEcCtD
Lorazepam—Feeling abnormal—Dactinomycin—sarcoma	0.00215	0.00254	CcSEcCtD
Lorazepam—Hypotension—Mitoxantrone—sarcoma	0.00212	0.0025	CcSEcCtD
Lorazepam—Vertigo—Etoposide—sarcoma	0.00208	0.00245	CcSEcCtD
Lorazepam—Cardiac arrest—Epirubicin—sarcoma	0.00205	0.00242	CcSEcCtD
Lorazepam—Lethargy—Doxorubicin—sarcoma	0.00203	0.0024	CcSEcCtD
Lorazepam—Ataxia—Epirubicin—sarcoma	0.00202	0.00239	CcSEcCtD
Lorazepam—Somnolence—Mitoxantrone—sarcoma	0.00202	0.00238	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Vincristine—sarcoma	0.00201	0.00237	CcSEcCtD
Lorazepam—Fatigue—Vincristine—sarcoma	0.00201	0.00237	CcSEcCtD
Lorazepam—Convulsion—Etoposide—sarcoma	0.002	0.00236	CcSEcCtD
Lorazepam—Hyponatraemia—Doxorubicin—sarcoma	0.002	0.00236	CcSEcCtD
Lorazepam—Hypertension—Etoposide—sarcoma	0.002	0.00236	CcSEcCtD
Lorazepam—Constipation—Vincristine—sarcoma	0.00199	0.00235	CcSEcCtD
Lorazepam—Pain—Vincristine—sarcoma	0.00199	0.00235	CcSEcCtD
Lorazepam—Diplopia—Doxorubicin—sarcoma	0.00199	0.00235	CcSEcCtD
Lorazepam—Osteoarthritis—Doxorubicin—sarcoma	0.00199	0.00235	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00199	0.00235	CcSEcCtD
Lorazepam—Liver function test abnormal—Epirubicin—sarcoma	0.00199	0.00235	CcSEcCtD
Lorazepam—Fatigue—Mitoxantrone—sarcoma	0.00196	0.00231	CcSEcCtD
Lorazepam—Constipation—Mitoxantrone—sarcoma	0.00194	0.00229	CcSEcCtD
Lorazepam—Pain—Mitoxantrone—sarcoma	0.00194	0.00229	CcSEcCtD
Lorazepam—Hypersensitivity—Thiotepa—sarcoma	0.00194	0.00228	CcSEcCtD
Lorazepam—Hypersensitivity—Dactinomycin—sarcoma	0.00192	0.00227	CcSEcCtD
Lorazepam—Confusional state—Etoposide—sarcoma	0.0019	0.00225	CcSEcCtD
Lorazepam—Cardiac arrest—Doxorubicin—sarcoma	0.00189	0.00224	CcSEcCtD
Lorazepam—Asthenia—Thiotepa—sarcoma	0.00189	0.00222	CcSEcCtD
Lorazepam—Infection—Etoposide—sarcoma	0.00188	0.00221	CcSEcCtD
Lorazepam—Ataxia—Doxorubicin—sarcoma	0.00187	0.00221	CcSEcCtD
Lorazepam—Asthenia—Dactinomycin—sarcoma	0.00187	0.00221	CcSEcCtD
Lorazepam—Feeling abnormal—Mitoxantrone—sarcoma	0.00187	0.00221	CcSEcCtD
Lorazepam—Thrombocytopenia—Etoposide—sarcoma	0.00185	0.00218	CcSEcCtD
Lorazepam—Tachycardia—Etoposide—sarcoma	0.00184	0.00217	CcSEcCtD
Lorazepam—Liver function test abnormal—Doxorubicin—sarcoma	0.00184	0.00217	CcSEcCtD
Lorazepam—Pancytopenia—Epirubicin—sarcoma	0.00177	0.00209	CcSEcCtD
Lorazepam—Hypotension—Etoposide—sarcoma	0.00176	0.00208	CcSEcCtD
Lorazepam—Dizziness—Thiotepa—sarcoma	0.00174	0.00205	CcSEcCtD
Lorazepam—Hypersensitivity—Vincristine—sarcoma	0.00172	0.00203	CcSEcCtD
Lorazepam—Somnolence—Etoposide—sarcoma	0.00168	0.00198	CcSEcCtD
Lorazepam—Hypersensitivity—Mitoxantrone—sarcoma	0.00167	0.00197	CcSEcCtD
Lorazepam—Asthenia—Vincristine—sarcoma	0.00167	0.00197	CcSEcCtD
Lorazepam—Vomiting—Thiotepa—sarcoma	0.00167	0.00197	CcSEcCtD
Lorazepam—Drowsiness—Epirubicin—sarcoma	0.00166	0.00196	CcSEcCtD
Lorazepam—Vomiting—Dactinomycin—sarcoma	0.00166	0.00196	CcSEcCtD
Lorazepam—Rash—Thiotepa—sarcoma	0.00166	0.00196	CcSEcCtD
Lorazepam—Dermatitis—Thiotepa—sarcoma	0.00166	0.00195	CcSEcCtD
Lorazepam—Headache—Thiotepa—sarcoma	0.00165	0.00194	CcSEcCtD
Lorazepam—Rash—Dactinomycin—sarcoma	0.00164	0.00194	CcSEcCtD
Lorazepam—Pancytopenia—Doxorubicin—sarcoma	0.00164	0.00193	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Etoposide—sarcoma	0.00163	0.00192	CcSEcCtD
Lorazepam—Asthenia—Mitoxantrone—sarcoma	0.00163	0.00192	CcSEcCtD
Lorazepam—Fatigue—Etoposide—sarcoma	0.00163	0.00192	CcSEcCtD
Lorazepam—Jaundice—Epirubicin—sarcoma	0.00162	0.00191	CcSEcCtD
Lorazepam—Constipation—Etoposide—sarcoma	0.00161	0.0019	CcSEcCtD
Lorazepam—Pain—Etoposide—sarcoma	0.00161	0.0019	CcSEcCtD
Lorazepam—Nausea—Thiotepa—sarcoma	0.00156	0.00184	CcSEcCtD
Lorazepam—Feeling abnormal—Etoposide—sarcoma	0.00156	0.00184	CcSEcCtD
Lorazepam—Nausea—Dactinomycin—sarcoma	0.00155	0.00183	CcSEcCtD
Lorazepam—Agranulocytosis—Epirubicin—sarcoma	0.00155	0.00183	CcSEcCtD
Lorazepam—Dizziness—Vincristine—sarcoma	0.00154	0.00182	CcSEcCtD
Lorazepam—Drowsiness—Doxorubicin—sarcoma	0.00154	0.00181	CcSEcCtD
Lorazepam—Bradycardia—Epirubicin—sarcoma	0.00152	0.00179	CcSEcCtD
Lorazepam—Jaundice—Doxorubicin—sarcoma	0.0015	0.00177	CcSEcCtD
Lorazepam—Vomiting—Vincristine—sarcoma	0.00148	0.00175	CcSEcCtD
Lorazepam—Rash—Vincristine—sarcoma	0.00147	0.00173	CcSEcCtD
Lorazepam—Dermatitis—Vincristine—sarcoma	0.00147	0.00173	CcSEcCtD
Lorazepam—Headache—Vincristine—sarcoma	0.00146	0.00172	CcSEcCtD
Lorazepam—Vomiting—Mitoxantrone—sarcoma	0.00144	0.0017	CcSEcCtD
Lorazepam—Visual impairment—Epirubicin—sarcoma	0.00144	0.00169	CcSEcCtD
Lorazepam—Agranulocytosis—Doxorubicin—sarcoma	0.00143	0.00169	CcSEcCtD
Lorazepam—Rash—Mitoxantrone—sarcoma	0.00143	0.00169	CcSEcCtD
Lorazepam—Dermatitis—Mitoxantrone—sarcoma	0.00143	0.00169	CcSEcCtD
Lorazepam—Headache—Mitoxantrone—sarcoma	0.00142	0.00168	CcSEcCtD
Lorazepam—Bradycardia—Doxorubicin—sarcoma	0.0014	0.00166	CcSEcCtD
Lorazepam—Hypersensitivity—Etoposide—sarcoma	0.00139	0.00164	CcSEcCtD
Lorazepam—Nausea—Vincristine—sarcoma	0.00138	0.00163	CcSEcCtD
Lorazepam—Asthenia—Etoposide—sarcoma	0.00135	0.0016	CcSEcCtD
Lorazepam—Nausea—Mitoxantrone—sarcoma	0.00135	0.00159	CcSEcCtD
Lorazepam—Chills—Epirubicin—sarcoma	0.00134	0.00158	CcSEcCtD
Lorazepam—Arrhythmia—Epirubicin—sarcoma	0.00133	0.00157	CcSEcCtD
Lorazepam—Visual impairment—Doxorubicin—sarcoma	0.00133	0.00157	CcSEcCtD
Lorazepam—Alopecia—Epirubicin—sarcoma	0.00132	0.00155	CcSEcCtD
Lorazepam—Erythema—Epirubicin—sarcoma	0.0013	0.00153	CcSEcCtD
Lorazepam—Tension—Epirubicin—sarcoma	0.00127	0.0015	CcSEcCtD
Lorazepam—Nervousness—Epirubicin—sarcoma	0.00126	0.00149	CcSEcCtD
Lorazepam—Dizziness—Etoposide—sarcoma	0.00125	0.00147	CcSEcCtD
Lorazepam—Chills—Doxorubicin—sarcoma	0.00124	0.00146	CcSEcCtD
Lorazepam—Arrhythmia—Doxorubicin—sarcoma	0.00123	0.00145	CcSEcCtD
Lorazepam—Vision blurred—Epirubicin—sarcoma	0.00122	0.00144	CcSEcCtD
Lorazepam—Alopecia—Doxorubicin—sarcoma	0.00122	0.00144	CcSEcCtD
Lorazepam—Vomiting—Etoposide—sarcoma	0.0012	0.00142	CcSEcCtD
Lorazepam—Erythema—Doxorubicin—sarcoma	0.0012	0.00142	CcSEcCtD
Lorazepam—Agitation—Epirubicin—sarcoma	0.00119	0.00141	CcSEcCtD
Lorazepam—Rash—Etoposide—sarcoma	0.00119	0.0014	CcSEcCtD
Lorazepam—Dermatitis—Etoposide—sarcoma	0.00119	0.0014	CcSEcCtD
Lorazepam—Headache—Etoposide—sarcoma	0.00118	0.0014	CcSEcCtD
Lorazepam—Tension—Doxorubicin—sarcoma	0.00118	0.00139	CcSEcCtD
Lorazepam—Nervousness—Doxorubicin—sarcoma	0.00117	0.00137	CcSEcCtD
Lorazepam—Vertigo—Epirubicin—sarcoma	0.00117	0.00137	CcSEcCtD
Lorazepam—Vision blurred—Doxorubicin—sarcoma	0.00113	0.00133	CcSEcCtD
Lorazepam—Convulsion—Epirubicin—sarcoma	0.00112	0.00133	CcSEcCtD
Lorazepam—Nausea—Etoposide—sarcoma	0.00112	0.00132	CcSEcCtD
Lorazepam—Hypertension—Epirubicin—sarcoma	0.00112	0.00132	CcSEcCtD
Lorazepam—Agitation—Doxorubicin—sarcoma	0.0011	0.0013	CcSEcCtD
Lorazepam—Dry mouth—Epirubicin—sarcoma	0.00108	0.00127	CcSEcCtD
Lorazepam—Vertigo—Doxorubicin—sarcoma	0.00108	0.00127	CcSEcCtD
Lorazepam—Confusional state—Epirubicin—sarcoma	0.00107	0.00126	CcSEcCtD
Lorazepam—Infection—Epirubicin—sarcoma	0.00105	0.00124	CcSEcCtD
Lorazepam—Convulsion—Doxorubicin—sarcoma	0.00104	0.00123	CcSEcCtD
Lorazepam—Thrombocytopenia—Epirubicin—sarcoma	0.00104	0.00122	CcSEcCtD
Lorazepam—Hypertension—Doxorubicin—sarcoma	0.00104	0.00122	CcSEcCtD
Lorazepam—Tachycardia—Epirubicin—sarcoma	0.00103	0.00122	CcSEcCtD
Lorazepam—Dry mouth—Doxorubicin—sarcoma	0.000999	0.00118	CcSEcCtD
Lorazepam—Hypotension—Epirubicin—sarcoma	0.000989	0.00117	CcSEcCtD
Lorazepam—Confusional state—Doxorubicin—sarcoma	0.000987	0.00116	CcSEcCtD
Lorazepam—Infection—Doxorubicin—sarcoma	0.000973	0.00115	CcSEcCtD
Lorazepam—Thrombocytopenia—Doxorubicin—sarcoma	0.000959	0.00113	CcSEcCtD
Lorazepam—Tachycardia—Doxorubicin—sarcoma	0.000956	0.00113	CcSEcCtD
Lorazepam—Somnolence—Epirubicin—sarcoma	0.000941	0.00111	CcSEcCtD
Lorazepam—Hypotension—Doxorubicin—sarcoma	0.000915	0.00108	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Epirubicin—sarcoma	0.000914	0.00108	CcSEcCtD
Lorazepam—Fatigue—Epirubicin—sarcoma	0.000912	0.00108	CcSEcCtD
Lorazepam—Pain—Epirubicin—sarcoma	0.000905	0.00107	CcSEcCtD
Lorazepam—Constipation—Epirubicin—sarcoma	0.000905	0.00107	CcSEcCtD
Lorazepam—Feeling abnormal—Epirubicin—sarcoma	0.000872	0.00103	CcSEcCtD
Lorazepam—Somnolence—Doxorubicin—sarcoma	0.000871	0.00103	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000845	0.000997	CcSEcCtD
Lorazepam—Fatigue—Doxorubicin—sarcoma	0.000844	0.000996	CcSEcCtD
Lorazepam—Pain—Doxorubicin—sarcoma	0.000837	0.000988	CcSEcCtD
Lorazepam—Constipation—Doxorubicin—sarcoma	0.000837	0.000988	CcSEcCtD
Lorazepam—Feeling abnormal—Doxorubicin—sarcoma	0.000807	0.000952	CcSEcCtD
Lorazepam—Hypersensitivity—Epirubicin—sarcoma	0.00078	0.00092	CcSEcCtD
Lorazepam—Asthenia—Epirubicin—sarcoma	0.000759	0.000896	CcSEcCtD
Lorazepam—Hypersensitivity—Doxorubicin—sarcoma	0.000721	0.000851	CcSEcCtD
Lorazepam—Asthenia—Doxorubicin—sarcoma	0.000703	0.000829	CcSEcCtD
Lorazepam—Dizziness—Epirubicin—sarcoma	0.0007	0.000826	CcSEcCtD
Lorazepam—Vomiting—Epirubicin—sarcoma	0.000673	0.000794	CcSEcCtD
Lorazepam—Rash—Epirubicin—sarcoma	0.000667	0.000787	CcSEcCtD
Lorazepam—Dermatitis—Epirubicin—sarcoma	0.000667	0.000787	CcSEcCtD
Lorazepam—Headache—Epirubicin—sarcoma	0.000663	0.000782	CcSEcCtD
Lorazepam—Dizziness—Doxorubicin—sarcoma	0.000648	0.000764	CcSEcCtD
Lorazepam—Nausea—Epirubicin—sarcoma	0.000629	0.000742	CcSEcCtD
Lorazepam—Vomiting—Doxorubicin—sarcoma	0.000623	0.000735	CcSEcCtD
Lorazepam—Rash—Doxorubicin—sarcoma	0.000617	0.000728	CcSEcCtD
Lorazepam—Dermatitis—Doxorubicin—sarcoma	0.000617	0.000728	CcSEcCtD
Lorazepam—Headache—Doxorubicin—sarcoma	0.000613	0.000724	CcSEcCtD
Lorazepam—Nausea—Doxorubicin—sarcoma	0.000582	0.000686	CcSEcCtD
